Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Shuhe granule is a traditional Chinese medicine (TCM) formula developed as a botanical drug for the treatment of insomnia, particularly in patients with "qi-blood disharmony" according to TCM theory. It is composed of 13 botanical ingredients, including Neolitsea cassia (Guizhi), Paeonia lactiflora (Baishao), Zingiber officinale (Shengjiang), Glycyrrhiza uralensis (Gancao), Ziziphus jujuba (Dazao), Panax ginseng (Renshen), Angelica sinensis (Danggui), and Ophiopogon japonicus among others. The preparation involves extraction, concentration, drying, and granulation using modern pharmaceutical technology. Its purported mechanism in TCM is to reconcile qi and blood and to warm and tonify the heart and kidney. Clinical studies are ongoing to evaluate its efficacy and safety for chronic insomnia[6][7][2].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Shuhe granule.